Kate Bingham

Dame Catherine Elizabeth Bingham (born 19 October 1965) is a British venture capitalist. She is a managing partner at a venture capital firm, SV Health Investors. In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines and the strategy for their deployment during the COVID-19 pandemic in the United Kingdom. Early life and education Bingham was born in London, the only daughter of the barrister and judge Tom Bingham (later Lord Bingham of Cornhill) and Elizabeth ( Loxley) and the eldest of their three children. She attended St Paul's Girls' School, London, before going on to study at the University of Oxford where she was an undergraduate student of Christ Church, Oxford, where she graduated with a first-class degree in Biochemistry (MA). Bingham then pursued further studies at Harvard Business School, taking the degree of MBA. Career Bingham worked in business development for Vertex Pharmaceuticals and consultants Monitor Company before joining Schroder Ventures in 1991 (now SV Health Investments). She became a managing partner specializing in biotechnology, and has served on the boards of companies in the UK, US, Ireland, Sweden and Germany, including Autifony Therapeutics, Bicycle Therapeutics (named for their specialism in bicyclic peptides), Mestag Therapeutics, Pulmocide, Sitryx, and Zarodex Therapeutics.